The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - PathomIQ
Leadership - PathomIQ
Stock and Other Ownership Interests - PathomIQ
Patents, Royalties, Other Intellectual Property - PathomIQ
A novel, AI-generated morphologic biomarker to predict prostate cancer recurrence in patients with intermediate risk of progression.
 
Sujit Nair
No Relationships to Disclose
 
Hassan Muhammad
Employment - Pathomiq
 
Parag Jain
Employment - PathomIQ
Stock and Other Ownership Interests - PathomIQ
Patents, Royalties, Other Intellectual Property - Patents pending in the area of biomarker discovery using AI on histopathology data for patient outcome prediction.
 
Chensu Xie
Employment - PathomIQ
Research Funding - PathomIQ
Patents, Royalties, Other Intellectual Property - I received royalty distribution from Memorial Sloan Kettering Cancer Center as the inventor of 2 patents.
 
Ina Pavlova
No Relationships to Disclose
 
Rachel Brody
No Relationships to Disclose
 
Wei Huang
Employment - Abbott (I)
Stock and Other Ownership Interests - PathomIQ
Research Funding - PathomIQ
 
Maria Nakadar
No Relationships to Disclose
 
Xiangfu Zhang
No Relationships to Disclose
 
Hirak S Basu
Stock and Other Ownership Interests - Colby Pharmaceutical; PathomIQ
Patents, Royalties, Other Intellectual Property - Issued patents: 9,023,837 8,466,130 7,491,849 7,453,011 7,235,695 7,186,825 7,026,347 6,982,351 6,794,545 5,880,161 5,541,230
Travel, Accommodations, Expenses - Dhristi
 
George Wilding
Employment - PathomiQ; Senex Biotechnology
Leadership - AIQ Solutions; PathomIQ; Senex Biotechnology
Stock and Other Ownership Interests - AIQ Solutions; PathomIQ; Senex Biotechnology
Consulting or Advisory Role - Cullgen; Leidos Biomedical Research
 
Dimple Chakravarty
No Relationships to Disclose
 
Rajat Roy
No Relationships to Disclose
 
Ashutosh K. Tewari
No Relationships to Disclose